Ambulatory Infusion Center Market

Ambulatory Infusion is the administration of chemotherapy, medications or fluids into the bloodstream through a needle or catheter. Ambulatory Infusion Center helps patients who require infusions of chemotherapy, antibiotics, blood products or other therapies on an outpatient basis.
An overpressure event refers to any condition which would cause pressure in a vessel or system to increase beyond the specified design pressure or maximum allowable working pressure (MAWP).
The primary purpose of a pressure Relief Valve is protection of life and property by venting fluid from an overpressurized vessel.
The spring-loaded relief valve is a conventional pressure relief valve that is commonly used in liquid service valves. The valve opens proportionally as the pressure increases to overcome the spring pressure.
Ambulatory Infusion Center Market contains market size and forecasts of Ambulatory Infusion Center in Global, including the following market information:
Global Ambulatory Infusion Center Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Ambulatory Infusion Center market was valued at 75440 million in 2021 and is projected to reach US$ 133690 million by 2028, at a CAGR of 8.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hospital Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ambulatory Infusion Center include Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, UK HealthCare, CHI Health, Accredo Health and PharMerica and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ambulatory Infusion Center companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ambulatory Infusion Center Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Ambulatory Infusion Center Market Segment Percentages, by Type, 2021 (%)
Hospital
Clinic
Home Health Agencies
Global Ambulatory Infusion Center Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Ambulatory Infusion Center Market Segment Percentages, by Application, 2021 (%)
Cancer
Chronic Disease
Others
Global Ambulatory Infusion Center Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Ambulatory Infusion Center Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ambulatory Infusion Center revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Ambulatory Infusion Center revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Option Care Health
Coram CVS
UnitedHealth Group
HCA Healthcare
McLaren
UK HealthCare
CHI Health
Accredo Health
PharMerica
Cleveland Clinic